Stephen Hoffman

Stephen Hoffman

Direttore/Membro del Consiglio presso RESEARCH ALLIANCE CORP. II

Patrimonio netto: 7 229 $ in data 31/05/2026

72 anni
Health Technology
Finance
Consumer Services

Profilo

Stephen J.
Hoffman
was the founder of Somatogen, Inc., founded in 1987, where the title held was Vice President-Science & Technology from 1987 to 1990.
Current jobs include Chairman at Apic Bio, Inc. since 2021; Independent Director at Research Alliance Corp.
II since 2021; Independent Director at Talphera, Inc. since 2010; Director at Implicit Bioscience Ltd. since 2022; Director at Receptor Life Sciences, Inc. since 2021; and Director at BYOMass, Inc. since 2021.
Former jobs include Chief Executive Officer & Director at Aerpio Therapeutics LLC; Chief Executive Officer & Director at Aerpio Pharmaceuticals, Inc. from 2017 to 2019; Chairman at Bicycle Therapeutics Plc from 2016 to 2019; Chairman at Allos Therapeutics, Inc. from 2002 to 2012; Chairman at Anchiano Therapeutics Ltd. from 2018 to 2019; Director at Danforth Advisors LLC from 2020 to 2021; Director at Sirtris Pharmaceuticals, Inc. from 2004 to 2008; Non-Executive Director at Hovione Farmaciência SA; Managing Director at Skyline Management LLC from 2007 to 2014; Independent Director at Genocea Biosciences, Inc. from 2013 to 2017; Director at Concert Pharmaceuticals, Inc.; Director at KAI Pharmaceuticals, Inc.; Director at Proteon Therapeutics, Inc.; Independent Director at Dicerna Pharmaceuticals, Inc. from 2007 to 2021; Director at Helomics Corp.; Director at Tolerx, Inc.; Director at PPD Dermatology LLC; Director at Sutro Biopharma, Inc.; Director at Palleon Pharmaceuticals, Inc.; Director at Collegium Pharmaceutical, Inc.; Vice President-Science & Technology at Baxter International, Inc. from 1987 to 1990; General Partner at TVM Capital GmbH from 2003 to 2007; and General Partner at TVM Capital Corp.
from 2003 to 2007.
Education includes doctorate degrees from Northwestern University and The University of Colorado School of Medicine.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
24/04/2026 8.859 ( 0,02% ) 7 229 $ 31/05/2026

Posizioni attive di Stephen Hoffman

SocietàPosizioneInizio
TALPHERA, INC. Direttore/Membro del Consiglio 01/02/2010
RESEARCH ALLIANCE CORP. II Direttore/Membro del Consiglio 01/03/2021
Direttore/Membro del Consiglio 01/10/2022
Direttore/Membro del Consiglio 27/10/2021
Direttore/Membro del Consiglio 18/03/2021
Presidente 05/01/2021

Precedenti posizioni note di Stephen Hoffman

SocietàPosizioneFine
DICERNA PHARMACEUTICALS, INC. Direttore/Membro del Consiglio 28/12/2021
Direttore/Membro del Consiglio 01/12/2021
Direttore/Membro del Consiglio 01/11/2020
░░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Stephen Hoffman

Formazione di Stephen Hoffman

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

66

Relazioni di 1° grado

32

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private32

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Finance

Consumer Services

Health Services

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Technology Services

Commercial Services

Finance

  1. Mercati
  2. Insiders
  3. Stephen Hoffman
- 40%: I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA